Figure1 (Eletriptan Fig1)
Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 59651-104
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 59651-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure2 (Eletriptan Fig2)
Package Label-principal Display Panel-20 mg (1x6) Carton (Eletriptan Fig3)
This is a package of Eletriptan Hydrobromide Tablets that contains 6 unit-dose tablets. Each film-coated tablet has 20mg of Eletriptan hydrobromide. The usual dosage information is provided in the accompanying prescribing information. The package is child-resistant and should be stored between 20° to 25°C. The package is distributed by a pharmaceutical company based in East Windsor, NJ, and the tablets were made in India. The NDC number is 59651-104-69 and it is labeled for prescription use only.*
Package Label-principal Display Panel (40 mg (1x6) Carton)
Eletriptan Hydrobromide Tablets are a medication used to treat migraines. Each unit-dose package contains 6 tablets, each containing 40mg of eletriptan hydrobromide. The tablets are film-coated and must be stored at a controlled room temperature. The package is child-resistant. The manufacturer is Aurobindo and the product is made in India. The usual dosage information can be found in the accompanying prescribing information. The NDC number is 59651-105-69.*
Chemical Structure (Eletriptan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
